Anticoagulant and antithrombotic therapy in the PCI of NSTE-ACS

4_abdalla_jamil
Jamil Abdalla Saad
2014-04-22

SOLACI’S  PRESIDENT  2013/15
Belo Horizonte – MG / BRAZIL

More articles by this author

Transcatheter Aortic Valve Implantation: Step by Step

Daniel Chamié2014-04-22Instituto Dante Pazzanese de CardiologiaSão Paulo – Brasil   

Implante transcateter de bioprótesis aórtica. Selección de pacientes

Jorge Belardi2014-04-22Director del Departamento de Cardiología ICBA

Implante Transapical de Bioprotesis Aórtica Autoexpandible en Paciente Compasivo con Estenosis Aórtica Severa contraindicado para otros abordajes

Cohen Fernando2014-04-22Servicio de Hemodinamia y Cardiología IntervencionistaHospital Italiano de Buenos Aires

Cierre de Orejuela Auricular Izquierda: Técnica y Resultados

Aníbal Damonte2014-04-22Departamento de Hemodinamia y Cardiología IntervencionistaInstituto Cardiovascular de RosarioRosario, Argentina

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...